Ovid Therapeutics
OVID
OVID
70 hedge funds and large institutions have $11.9M invested in Ovid Therapeutics in 2025 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
27% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 22
39% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 28
Holders
70
Holding in Top 10
1
Calls
$5K
Puts
–
Top Buyers
| 1 | +$353K | |
| 2 | +$347K | |
| 3 | +$165K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$99.7K |
| 5 |
Goldman Sachs
New York
|
+$59.2K |
Top Sellers
| 1 | -$1.6M | |
| 2 | -$822K | |
| 3 | -$397K | |
| 4 |
MAP
Madison Avenue Partners
New York
|
-$381K |
| 5 |
State Street
Boston,
Massachusetts
|
-$378K |
